文献速递骨肌技术与安全CT

全身双源光子计数CT在多发性骨髓瘤中的应用——虚拟单能成像对病灶活性评估的价值

Whole-body Dual-source Photon-counting CT in Multiple Myeloma-The Value of Virtual Monoenergetic Imaging for Lesion Vitality Assessment.
PubMed 文献 · Invest Radiol · 2026-04-01

回顾性纳入51例多发性骨髓瘤患者,行全身双源光子计数CT平扫,由3名放射科医师测量169个溶骨性病灶(85个活动性)及周围组织CT值。活动性病灶40与70 keV虚拟单能图像的衰减差值明显大于非活动性病灶,病灶内脂肪、钙化及低密度环等定性特征在非活动性病灶中更常见。

要点

  • 活动性病灶40与70 keV虚拟单能图像衰减差值中位数19.3 HU,非活动性病灶为-3.8 HU。
  • 非活动性病灶更常见病灶内脂肪(72.2% vs 10.6%)、钙化(40.1% vs 1.6%)和低密度环(37.3% vs 0)。
  • 活动性病灶更常见密度均匀(86.3% vs 2.4%)和伪彩编码显著(94.9% vs 68.7%)。

核心结论

  • 全身双源光子计数CT显示,治疗反应者与初诊及疾病进展者在70至40 keV虚拟单能图像的衰减变化上存在显著差异,髓内病灶的异质性、部分再钙化或低密度环(「晕征」)可作为治疗反应的附加指标。

研究设计与样本

  • 回顾性研究纳入51例多发性骨髓瘤患者(年龄67.1±10.1岁,36名男性),于2024年10月至2025年2月行全身双源光子计数CT平扫,3名委员会认证放射科医师测量169个溶骨性病灶(85个活动性)及周围组织CT值,比较活动性与非活动性病灶40与70 keV的差异。

关键影像表现/征象

  • 活动性病灶40与70 keV虚拟单能图像衰减差值中位数19.3 HU(四分位距12.7-27.0),非活动性病灶为-3.8 HU(四分位距-26.1至17.0)。
  • 活动性病灶密度均匀者占86.3%,非活动性病灶占2.4%。
  • 活动性病灶伪彩编码显著者占94.9%,非活动性病灶占68.7%。
  • 非活动性病灶病灶内脂肪占72.2%、钙化占40.1%、低密度环占37.3%,活动性病灶分别为10.6%、1.6%和0。

诊断标准与关键数值

  • 40与70 keV虚拟单能图像衰减差值在活动性病灶中中位数为19.3 HU,非活动性病灶为-3.8 HU(P<0.001)。
  • 活动性与非活动性病灶间密度均匀(86.3% vs 2.4%)、伪彩编码显著(94.9% vs 68.7%)、病灶内脂肪(10.6% vs 72.2%)、钙化(1.6% vs 40.1%)、低密度环(0 vs 37.3%)差异均有统计学意义(均P<0.001)。
  • 测量者间信度极佳(组内相关系数≥0.95),所有定性标准的一致性高(Krippendorff α≥0.85)。

临床应用与阅片要点

  • 可结合40与70 keV虚拟单能图像的衰减差值及病灶内脂肪、钙化、低密度环等定性特征辅助判断骨髓瘤病灶活性。
  • 低密度环(「晕征」)、部分再钙化及病灶异质性可作为治疗反应的附加影像指标。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

RATIONALE AND OBJECTIVES: Dual-source photon-counting CT (DS-PCCT) facilitates an unprecedented combination of spectral information and ultra-high resolution in whole-body imaging of multiple myeloma. This study explored the distinct characteristics of soft tissue, fat, and calcium in virtual monoenergetic images (VMI) with low photon energy, aiming to identify criteria of lesion vitality.

MATERIALS AND METHODS: This retrospective study included 51 patients with multiple myeloma (67.1±10.1 y, 36 men) who underwent unenhanced whole-body DS-PCCT between October 2024 and February 2025. Three board-certified radiologists measured CT numbers within 169 osteolytic lesions (85 active) and their surrounding tissues. Differences between 40 and 70 keV were compared among active and inactive lesions. In addition, the presence of intralesional fat, calcifications, hypodense rims, homogeneity, and highlighting in color-coded virtual non-calcium maps was assessed subjectively.

RESULTS: The attenuation difference between 40 and 70 keV VMI was markedly larger in active than inactive lesions [median 19.3 (interquartile range: 12.7-27.0) vs. -3.8 (-26.1 to 17.0) HU; P <0.001]. Homogenous density (86.3% vs. 2.4%) and conspicuous color-coding (94.9 vs. 68.7%) were more common in active myeloma, whereas intralesional fat (10.6 vs. 72.2%), calcifications (1.6% vs. 40.1%), and hypodense rims (0 vs. 37.3%) were more frequent in inactive lesions (all P <0.001). Interrater measurement reliability was excellent (intraclass correlation coefficient ≥0.95), and agreement for all qualitative criteria was high (Krippendorff α ≥0.85).

CONCLUSIONS: This investigation on whole-body DS-PCCT demonstrated a significant difference in attenuation changes from 70 to 40 keV VMI across multiple myeloma patients with a therapy response versus initial diagnosis and disease progression. Qualitative characteristics of medullary lesions, such as heterogeneity, partial recalcification, or a hypodense rim ("halo sign"), can serve as additional indicators of therapy response.

来源:Invest Radiol,查看原文。版权归原作者所有。

引用

  1. Heidemeier A, Huflage H, Rasche L, et al. Whole-body Dual-source Photon-counting CT in Multiple Myeloma-The Value of Virtual Monoenergetic Imaging for Lesion Vitality Assessment. Invest Radiol. 2026. PMID: 40673657. doi:10.1097/RLI.0000000000001228

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。